AI-powered end-to-end solution for antibody discovery—from molecular modeling to wet lab, data analysis, and registration.
Geneious Biologics is cloud-based software for antibody discovery and engineering that analyzes antibody sequence data to identify, optimize, and prioritize therapeutic candidates. It supports Sanger, NGS, and single-cell datasets and annotates antibody types including mAb, Fab, scFv, VHH, TCR, and VH/VL pairs in a single collaborative workspace.
The Antibody Annotator assigns CDR/FR regions from germline or custom databases, identifies germline gene differences, and flags sequence liabilities. Results are clustered by sequence identity and displayed in an interactive table with filterable columns, graphs, and alignment views.
The series covers ten short videos spanning the full initial workflow: account activation and user management, platform navigation and file upload, Sanger and NGS sequence pre-processing, antibody annotation, results interpretation in graphs and data tables, adding bioassay data, sequence alignment, and exporting data.
Yes. Bioassay data can be imported from Excel or CSV files and merged with annotated sequences. Once integrated, assay values are searchable and filterable alongside sequence properties, and can be visualized in alignments and cluster graphs to support candidate prioritization.
Geneious Biologics accepts Sanger, NGS, and single-cell antibody sequence datasets. Files can be uploaded by drag-and-drop or via the Upload button, and the platform includes pre-processing pipelines for paired-end merging, batch Sanger assembly, barcode separation, and UMI deduplication.
Geneious Biologics is a cloud-based platform with folder-level sharing and permission controls. Organizations can collaborate in a shared workspace, and the platform holds ISO 27001:2013 certification for information security management.
Geneious Prime
Geneious Biologics